|
 |
quetiapine fumarateThis page contains recent news articles, when available, and an overview of quetiapine fumarate but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: quetiapine fumarate (when available) Quetiapine is a psychotropic agent belonging to the chemical class of benzisoxazole derivatives and is indicated for the treatment of schizophrenia. Quetiapine is a selective monoaminergic antagonist with high affinity for the serotonin Type 2 (5HT2), and dopamine type 2 (D2) receptors. Quetiapine is an antagonist at serotonin 5-HT1A and 5HT2, dopamine D1 and D2, histamine H1, and adrenergic alpha 1 and alpha 2 receptors. Quetiapine has no significant affinity for cholinergic muscarinic or benzodiazepine receptors. Drowsiness and orthostatic hypotension associated with use of quetiapine may be explained by its antagonism of histamine H1 and adrenergic alpha 1 receptors, respectively. Quetiapine's antagonism of adrenergic a1 receptors may explain the orthostatic hypotension observed with this drug. For the treatment of schizophrenia and acute manic episodes associated with bipolar I disorder, as either monotherapy or adjunct therapy to lithium or divalproex. Mechanism Of Action: The mechanism of action of quetiapine, as with other drugs used to treat schizophrenia, is unknown. However, it is thought that the drug's therapeutic activity in schizophrenia is mediated through a combination of dopamine type 2 (D2) and serotonin type 2 (5HT2) receptor antagonism. Although quetiapine is known to bind other receptors with similar affinity, only the dopamine D2 and serotonin 5HT2 receptor binding is responsible for quetiapine's therapeutic activity in schizophrenia. News Articles on Quetiapine Antipsychotic Use Among Young Children Up Despite Risks and Questions - 05 Jan 2010 Atypical antipsychotics generate more than $12 billion in sales every year, with Seroquel (quetiapine fumarate) leading the pack with nearly $4.45 billion ... AboutLawsuits.com AstraZeneca welcomes FDA decision on CRESTOR - Dec 16, 2009 Earlier this month, the company announced that the FDA has approved once-daily SEROQUEL XR (quetiapine fumarate) extended release tablets as an add-on ... Zenopa AstraZeneca to Pay $520 Million to Resolve Seroquel Dispute - Nov 11, 2009 California and Arkansas, that have sued or investigated the company over its alleged off-label promotion of Seroquel (quetiapine fumarate) and Seroquel XR. FDA news (subscription) AstraZeneca Sets Aside $520 Million To Settle Off-label Marketing Claims - Oct 30, 2009 ...$520 million to cover an expected settlement with federal investigators over its marketing of the antipsychotic drug Seroquel (quetiapine fumarate). ... Thompson.com 30 to 40 % of mental illnesses in UAE are schizophrenia-related - Oct 31, 2009 ...regulatory applications in both the US and European Union for Quetiapine Fumarate in the treatment of manic episodes associated with bipolar disorder, ... Al-Bawaba Bipolar drug market “to plummet from 2011â€? - Nov 10, 2009 ...by the patent expiries and subsequent generic erosion of a number of key antipsychotic agents including AstraZeneca's Seroquel (quetiapine fumarate), ... Pharma Times Zyprexa, Seroquel Use Among Kids Linked to Dramatic Weight Gain - Oct 28, 2009 Atypical antipsychotics generate more than $12 billion in sales every year, with Seroquel (quetiapine fumarate) leading the pack with nearly $4.45 billion ... AboutLawsuits.com FDA Approves Seroquel(R) (Quetiapine Fumarate) for Bipolar Depression... - Oct 20, 2006 LONDON, UK -- October 20, 2006 -- AstraZeneca today announced that the US Food and Drug Administration (FDA) approved Seroquel® (quetiapine fumarate) for ... DG News … - 73 FR 4583 Determination That SEROQUEL (Quetiapine Fumarate) … - Jan 25, 2008 SEROQUEL (quetiapine fumarate) tablets are in a class of medications called ... SEROQUEL (quetiapine fumarate) tablets may be used alone or with lithium or ... Pay-Per-View - Federal Register 2008 - Loislaw Studies Examine Quetiapine Fumarate in Combination With … - May 30, 2006 WILMINGTON, DE -- May 30 2006 -- AstraZeneca announced results of two clinical studies that examined Seroquel(R) (quetiapine fumarate) in combination with ... DG News New era for SEROQUEL® (quetiapine fumarate) - approval from the FDA - May 19, 2008 With the acceptance of SEROQUEL® (quetiapine fumarate) by the FDA to treat Bipolar disorder, medical research can yet again rely on extensive clinical ... Gerson Lehrman Group AstraZeneca Presents New Depression And Anxiety Results For … - Dec 5, 2007 The first data from the SEROQUEL XR™ (quetiapine fumarate) Extended Release ... Results from a phase III study of extended release quetiapine fumarate ... Medical News Today - Medical News Today (press release) … With SEROQUEL(R) (quetiapine fumarate) Examined in Separate St - May 23, 2005 Cognitive Function and Compliance With SEROQUEL(R) (quetiapine fumarate) Examined in Separate Studies in Patients With Schizophrenia. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research SEROQUEL XR™ Improved Anxiety Symptoms By Day 4 In Generalised … - Sep 1, 2008 In this study, extended release quetiapine fumarate significantly improved ... At week 8, extended release quetiapine fumarate 150mg/day, 300mg/day and ... Medical News Today - Medical News Today (press release) … further examines SeroquelÆ (quetiapine fumarate) treatment for... - May 20, 2005 WILMINGTON, Del, Tuesday May 24 2005 ñ AstraZeneca (NYSE: AZN) today announced additional findings at the annual meeting of the American Psychiatric ... PsychCentral.com … Examines SEROQUEL(R) (quetiapine fumarate) Treatment for Bipolar … - May 24, 2005 Data Further Examines SEROQUEL(R) (quetiapine fumarate) Treatment for Bipolar Depression. from PR Newswire. Highbeam Research – FREE Trial. Pay-Per-View - PR Newswire - HighBeam Research … -daily Seroquel XR (quetiapine fumarate) Extended-ReleaseTablets f - Dec 15, 2008 AstraZeneca announced the FDA has approved once-daily Seroquel XR (quetiapine fumarate) Extended-ReleaseTablets for the acute treatment of depressive ... $9.94 - Drug Topics - Alacra Store Press Release: AstraZeneca's Once-Daily SEROQUEL XR(TM) Extended … - Aug 29, 2007 Evaluation Board) has approved SEROQUEL XR(TM) (quetiapine fumarate ... schizophrenia in adult patients. With SEROQUEL XR(TM) patients can achieve ... well ... Pay-Per-View - PR Newswire Europe - HighBeam Research Health Canada Approves New Treatment for Bipolar Mania - Jun 7, 2008 Quetiapine fumarate was found to improve core symptoms of mania, ... The efficacy of quetiapine fumarate in the management of manic episodes associated with ... DG News Press Release: SEROQUEL XR(TM) Receives Approval From FDA for … - Nov 16, 2007 Administration (FDA) has approved SEROQUEL XR(TM) (quetiapine fumarate) Extended ... schizophrenia in adult patients. The SEROQUEL XR development program ... Pay-Per-View - PR Newswire - HighBeam Research Article: TAKING STOCK ; YOUR AT-A-GLANCE GUIDE - Evening … - May 18, 2007 Administration (FDA) has approved SEROQUEL XR(TM) (quetiapine fumarate) Extended ... schizophrenia in adult patients. The SEROQUEL XR development program ... Pay-Per-View - Evening Standard - London - HighBeam Research Article: TAKING STOCK ; YOUR AT-A-GLANCE GUIDE - Evening … - May 18, 2007 Administration (FDA) has approved SEROQUEL XR(TM) (quetiapine fumarate) Extended ... schizophrenia in adult patients. The SEROQUEL XR development program ... Pay-Per-View - Evening Standard - London - HighBeam Research AstraZeneca Submits SNDA For SEROQUEL(R) For Bipolar Depression … - Jan 3, 2006 SEROQUEL(R) (quetiapine fumarate) is the #1 prescribed atypical antipsychotic in the United States(10) and has a well-established safety and efficacy ... Medical News Today - Medical News Today (press release) Bloomberg Printer-Friendly Page - Jan 2, 2008 ...studies were comparable to the FDA-approved recommended doses for SEROQUEL (quetiapine fumarate) immediate release tablets in those indications(1,2). ... Bloomberg Press Release: Head to Head Study Confirms Atypical Antipsychotic … - Oct 22, 2005 Study Results Suggest SEROQUEL May Reduce Symptoms of Agitation Associated ... that examined the effectiveness of SEROQUEL(R) (quetiapine fumarate) in the ... Pay-Per-View - PR Newswire - HighBeam Research FDA Requires Additional Data For Seroquel XR Supplemental New Drug … - Dec 26, 2008 The US FDA (Food and Drug Administration) has asked AstraZeneca, the makers of Seroquel XR (quetiapine fumarate), for additional information for its ... Medical News Today - Medical News Today (press release) New Studies Examine SEROQUEL(R) in Combination With … - May 22, 2006 SEROQUEL(R) (quetiapine fumarate) is indicated for the treatment of acute manic episodes associated with bipolar I disorder, as either monotherapy or ... $4.95 - PR Newswire - ECNext Article: AZ's Seroquel faces competition.(Astra-Zeneca drug competitio... - Oct 17, 2005 Swedish drug major AstraZeneca says its Seroquel (quetiapine fumarate) significantly ... for at least 12 weeks with open label Seroquel (400-800mg/day) plus ... Pay-Per-View - Chemistry and Industry - HighBeam Research Press Release: New Study Analyses Confirm Once-Daily SEROQUEL XR … - May 22, 2007 AstraZeneca today launched its once-daily SEROQUEL XR(R) (quetiapine fumarate) Extended ... adjunctive therapy to lithium or divalproex. ... Pay-Per-View - PR Newswire - HighBeam Research Study Confirms Seroquel(R) as Effective as Risperidone for Treatment... - Aug 3, 2006 The study, known as QUARTZ (Quetiapine Fumarate and Risperidone in the Treatment of ... Seroquel® (quetiapine fumarate) has a well-established safety and ... DG News AstraZeneca PLC AZN Seroquel XR CRL - Dec 24, 2008 SEROQUEL XR, a once-daily, extended release formulation of SEROQUEL (quetiapine fumarate), was approved in the US in 2007 for the acute and maintenance ... Bloomberg AstraZeneca Submits sNDA for SEROQUEL(R) for Bipolar Depression … - Dec 30, 2005 SEROQUEL(R) (quetiapine fumarate) is the #1 prescribed atypical antipsychotic in the United States(10) and has a well-established safety and efficacy ... Free with registration - PR Newswire - AccessMyLibrary.com Press Release: Summary Judgment Granted for SEROQUEL(R) Patent … - Jul 1, 2008 Drug Administration (FDA) has approved SEROQUEL(R) (quetiapine fumarate tablets ... adjunct therapy to lithium or divalproex. SEROQUEL is approved by the ... Pay-Per-View - PR Newswire - HighBeam Research AstraZeneca's SEROQUEL Named 'Product of the Year' by National … - Oct 31, 2005 SEROQUEL (quetiapine fumarate) is an atypical antipsychotic approved for the ... For full Prescribing Information for SEROQUEL(R) (quetiapine fumarate) ... Free with registration - PR Newswire - AccessMyLibrary.com FDA Approves AstraZeneca's Seroquel(c) For Bipolar Depression … - Oct 23, 2006 AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved SEROQUEL(c) (quetiapine fumarate) for the treatment of patients with ... Medical News Today - Medical News Today (press release) Press Release: New Studies Examine SEROQUEL(R) in Combination … - May 22, 2006 Article: Patients Prefer SEROQUEL(R) (quetiapine fumarate) ... PR Newswire; October 1, 1998 ; 700+ words ... ... effects. Greater patient satisfaction ... Pay-Per-View - PR Newswire - HighBeam Research SEROQUEL(R) Sustained Release Schizophrenia Data Presented at … - Mar 18, 2007 The data demonstrated that the SEROQUEL(R) sustained release formulation (quetiapine fumarate sustained release), administered once daily, ... ots.at Article: HOW TO GET BACK IN SHAPE IF YOU'VE STUBBED OUT THE … - Mar 28, 2006 AstraZeneca today announced SEROQUEL(R) sustained release formulation (quetiapine fumarate sustained release) clinical trial data presented at ... ... Pay-Per-View - Daily Record - HighBeam Research Press Release: AstraZeneca's SEROQUEL Named 'Product of the Year' … - Oct 31, 2005 Study Results Suggest SEROQUEL May Reduce Symptoms of Agitation Associated ... that examined the effectiveness of SEROQUEL(R) (quetiapine fumarate) in the ... Pay-Per-View - PR Newswire - HighBeam Research New Study Analyses Confirm Once-Daily SEROQUEL XR(TM) Extended- … - May 22, 2007 ...efficacy of SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets, a once-daily medicine for the treatment of schizophrenia in adult patients, ... $4.95 - PR Newswire - ECNext Loislaw Federal District Court Opinions - THOMAS v. ASTRUE (Minn. 7-7... - Jul 7, 2008 Id. The Plaintiff was then taking Fluoxetine, Hydrochlorothiazide, Page 10 Hydrocodone, Methocarbamol, Quetiapine Fumarate, and Tramadol. ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Bolder II Study Confirms Efficacy of Seroquel(R) for Bipolar Depressio... - Nov 17, 2006 Regulatory filings for the treatment of schizophrenia with a sustained release formulation of quetiapine fumarate, Seroquel SR™, were submitted this year to ... DG News The New Year in Psychiatry - Jan 18, 2007 The second generation antipsychotics were Zyprexa (olanzapine), Geodon (ziprasidone), Seroquel (quetiapine fumarate), and Risperdal (risperidone). ... MedPage Today AstraZeneca Submits sNDA for SEROQUEL(R) for Bipolar Depression … - Mar 1, 2006 SEROQUEL(R) (quetiapine fumarate) is the number one prescribed atypical antipsychotic in the United States(7) and has a well-established safety and efficacy ... presseportal.de PRESS RELEASE: AstraZeneca Presents New Depression and Anxiety … - Dec 6, 2007 The first data from the SEROQUEL XR™ (quetiapine fumarate) Extended Release ... SEROQUEL (quetiapine fumarate), both directly and indirectly (via its major ... FierceBiotech FDA Sends AstraZeneca Letter About Seroquel - Dec 5, 2008 ...regarding its drugs, Seroquel (quetiapine fumarate) tablets (Seroquel) and Seroquel XRTM (quetiapine fumarate) Extended Release Tablets (Seroquel XR). ... FierceBiotech Press Release: AstraZeneca Submits sNDA for SEROQUEL(R) for Bipolar … - Dec 30, 2005 SEROQUEL(R) (quetiapine fumarate) is the #1 prescribed atypical antipsychotic in the United States(10) and has a well-established safety and efficacy ... Pay-Per-View - PR Newswire - HighBeam Research AstraZeneca Submits NDA For Sustained Release Formulation Of … - Jul 19, 2006 SEROQUEL(R) (quetiapine fumarate) is not approved for the treatment of patients with dementia-related psychosis. Prescribing should be consistent with the ... Medical News Today - Medical News Today (press release) Antipsychotic Drugs May Improve Neurocognition in Patients With … - Jun 5, 2007 The objective of this study was to compare the neurocognitive effects of several second-generation antipsychotics (olanzapine, quetiapine fumarate, ... Medscape Astrazeneca Submits Seroquel XR For The Treatment Of Bipolar Mania … - Feb 11, 2008 AstraZeneca also announced it has submitted a further application in the EU for SEROQUEL® (quetiapine fumarate immediate release, IR) for the treatment of ... Medical News Today - Medical News Today (press release) Updated Bipolar Disorder Guidelines include Seroquel as a first line ... - Nov 30, 2006 The guidelines consider Seroquel™ (quetiapine fumarate) as a first-line single medication for bipolar depression and a second-line option for the management ... DG News Press Release: FDA Approves AstraZeneca's SEROQUEL XR(R) for the … - Oct 10, 2008 Drug Administration approval for Seroquel XR (quetiapine fumarate) extended ... manic episodes associated with bipolar disorder. The therapy is now cleared ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Second Investigational Study of SEROQUEL(R) in the … - May 23, 2006 Article: Data Further Examines SEROQUEL(R) (quetiapine fumarate) ... PR Newswire; May 24, 2005 ; 700+ words ... ... from the BOLDER (BipOLar DEpRession) ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: SEROQUEL(R) Sustained Release Schizophrenia Data … - Mar 18, 2007 The data demonstrated that the SEROQUEL(R) sustained release formulation (quetiapine fumarate sustained release), administered once daily, ... Pay-Per-View - PR Newswire Europe - HighBeam Research AstraZeneca submits sNDA for SEROQUEL XR for treatment of major … - Mar 1, 2008 Launched in 1997, SEROQUEL(R) (quetiapine fumarate tablets) has been prescribed to millions of patients worldwide. It is approved in 88 countries for the ... News-Medical.net Press Release: NIMH-Funded Study Examines the Use of Antipsychotic … - Sep 19, 2005 Article: FDA Clears Zeneca's SEROQUEL(R) (quetiapine fumarate) ... PR Newswire; September 30, 1997 ; 700+ words ... ... demonstrate that therapy with ... Pay-Per-View - PR Newswire - HighBeam Research New Analysis Highlights Potential Of SEROQUEL For Long-term … - Jan 28, 2008 Once daily SEROQUEL® XR (quetiapine fumarate extended release tablets) was launched for the treatment of schizophrenia in the US in 2007, and its clinical ... Medical News Today - Medical News Today (press release) AstraZeneca Submits Seroquel XR™ in Europe for the Treatment of … - Feb 13, 2008 AstraZeneca also announced it has submitted a further application in the EU for SEROQUEL® (quetiapine fumarate immediate release, IR) for the treatment of ... webwire.com Press Release: Study Examines SEROQUEL and the Risk of … - Mar 6, 2005 Article: FDA Clears Zeneca's SEROQUEL(R) (quetiapine fumarate) ... PR Newswire; September 30, 1997 ; 700+ words ... ... other antipsychotics, ... Pay-Per-View - PR Newswire - HighBeam Research Article: AstraZeneca submits sNDA for SEROQUEL[R] for bipolar … - Feb 1, 2006 ...for a new indication for SEROQUEL[R] (quetiapine fumarate) for the treatment of patients with depressive episodes associated with bipolar disorder. ... Pay-Per-View - Pharmaceutical Processing - HighBeam Research Press Release: Shire to Present Additional Scientific Data on ADHD … - May 1, 2008 3) About a poster presentation entitled: Efficacy of Once-Daily Extended Release Quetiapine Fumarate ... 1) About a poster presentation entitled: Efficacy ... Pay-Per-View - PR Newswire - HighBeam Research FDA Approval Decisions Report December-February 2009 - Dec 1, 2008 AstraZeneca plc (ADR) (AZN) / Seroquel XR (Quetiapine Fumarate Sustained Release). Manic Episodes Associated With Bipolar. Disorder ... $125.00 - Revere Reports - Revere FDA Approval Decisions Report November-January 2009 - Nov 1, 2008 AstraZeneca plc (ADR) (AZN) / Seroquel XR (Quetiapine Fumarate Sustained Release). Manic Episodes Associated With Bipolar. Disorder ... $125.00 - Revere Reports - Revere AstraZeneca's Plan, Icahn's Success, S&P Record: David Wilson - Apr 24, 2007 ...to sell a generic version of the schizophrenia drug and has filed suit to overturn AstraZeneca's patent on its active ingredient, quetiapine fumarate. ... Bloomberg AstraZeneca files US suit against Teva over Seroquel patent infringeme... - Nov 9, 2005 ...regarding Teva's intent to market a generic version of Seroquel (quetiapine fumarate) in the US prior to the expiration of AstraZeneca's Patent No. ... Forbes Teva Announces Tentative Approval of Generic Seroquel® Tablets - Dec 23, 2008 New Drug Application (ANDA) to market its generic version of AstraZeneca's antipsychotic agent Seroquel® (Quetiapine Fumarate) Tablets, Eq. 25 mg base, ... Bloomberg Bipolar children – is the US overdiagnosing? - May 16, 2007 She was also taking the anti-convulsant Depakote (valproate) and the anti-psychotic Seroquel (quetiapine fumarate) to stabilise her mood. ... New Scientist Zyprexa Edges Four Other Agents With Modest Benefit for Schizophrenia - Sep 19, 2005 And the time to discontinuation was significantly longer among the Zyprexa patients than in the Seroquel (quetiapine fumarate) arm (P<0.001) or the ... MedPage Today Atlanta health, diet and fitness news | ajc.com - Feb 20, 2007 This study will evaluate the safety and efficacy of sustained-release quetiapine fumarate (Seroquel) for eight weeks to treat acute bipolar depression. ... Atlanta Journal Constitution AstraZeneca applies for schizophrenia drug approval - Oct 20, 2006 UK-based pharmaceutical firm AstraZeneca has filed a new version of its Seroquel (quetiapine fumarate) drug for regulatory approval in the EU and Canada. ... Hays Pharma Drug agency re-examining Lilly's Zyprexa data | Article from Internati... - Apr 26, 2007 Zyprexa (olanzapine), from Eli Lilly & Co., won approval in 1996. The new drugs ĂŁ also including Seroquel (quetiapine fumarate ... ... Pay-Per-View - International Herald Tribune - HighBeam Research AstraZeneca Seroquel Trial Date Set for August - Mar 12, 2008 The UK company claims the copies would infringe a patent it owns on quetiapine fumarate, the active ingredient in Seroquel. ... Bloomberg Wear v. Transamerica Life Insurance Co., No. 3:06-cv-244 (EDTenn. 11/... - Nov 1, 2007 ...fn8 These same medical records, according to Ms. Davis's review, also show that Mr. Wear was taking "Paroxetine, an anti-depressant, and Quetiapine Fumarate ... $2.95 - U.S. District Court, Eastern District... - VersusLaw AstraZeneca Submits An NDA For Sustained Release Formulation … - Jul 24, 2006 SEROQUELĐľ (quetiapine fumarate) has a well-established safety and efficacy profile and to date over 16 million people have been treated worldwide. ... Medical News Today - Medical News Today (press release) AstraZeneca Seeks Additional Seroquel Approvals in EU - Feb 19, 2008 Last year, the FDA approved Seroquel XR (quetiapine fumarate) to treat schizophrenia, giving the extended-release formulation of the drug patent protection ... FDA news - FDA news (subscription) AstraZeneca Sues Novartis to Block Generic Seroquel - Apr 10, 2007 AstraZeneca claims the copies would infringe a patent it owns on quetiapine fumarate, the active ingredient in Seroquel. Sandoz's application challenges the ... Bloomberg Teva/Sandoz' challenge of AZ's US Seroquel patent set for Aug 2008. - Mar 17, 2008 11 start date for a trial relating to a patent challenge by Israeli generics giant Teva and Novartis' Sandoz on its drug Seroquel (quetiapine fumarate). ... $9.94 - Pharma Marketletter - Alacra Store Antipsychotic for bipolar disorder.(BEHAVIORAL HEALTH MONITOR) - Nov 1, 2006 The FDA has approved SEROQUEL[R] (quetiapine fumarate) for the treatment of patients with depressive episodes associated with bipolar disorder. ... $4.95 - Behavioral Healthcare - ECNext AstraZeneca Receives Patent Challenge - Sep 28, 2005 The drug, also known as quetiapine fumarate, had US sales of $1.5 billion in 2004. It has continued to perform well despite details of a clinical trial into ... RedOrbit Older Schizophrenia Drug Called More Cost-Effective Than Newer Ones - Dec 1, 2006 These were Zyprexa (olanzapine), Geodon (ziprasidone), Seroquel (quetiapine fumarate), and Risperdal (risperidone). The main result of the study, ... Psychiatric Times Quetiapine XR Shown to Improve Quality of Life of Patients With … - Mar 10, 2008 ...[Presentation title: Extended Release Once-Daily Monotherapy of Quetiapine Fumarate (Quetiapine XR), Paroxetine and Placebo in Generalized Anxiety Disorder ... DG News Loislaw Federal District Court Opinions - SHAH v. RHINEHART (WDPa. … - May 11, 2006 At the time of his transfer Plaintiff had been taking the prescription medication Quetiapine Fumarate, known by the brand name Seroquel, which is Page 3 ... Pay-Per-View - Loislaw Federal District Court Opinions - Loislaw Quetiapine Extended-Release May Be Effective for Generalized Anxiety ... - May 9, 2008 ...[Presentation title: Efficacy and Safety of Extended Release Quetiapine Fumarate (Quetiapine XR) Monotherapy in Patients With Generalized Anxiety Disorder ... DG News New Data Offers Hope to Patients With Bipolar Disorder and … - Sep 19, 2006 Quetiapine (quetiapine fumarate) has a well-established safety and efficacy profile and to date over 16 million people have been treated with quetiapine ... Newswit.com Sharp Rise in Young Patients Treated With Antipsychotics - Jun 6, 2006 Among the second-generation drugs were Clozaril (clozapine), Risperdal (risperidone), Zyprexa (olanzapine), and Seroquel (quetiapine fumarate). ... MedPage Today Mathematics for Understanding Disease - Jan 9, 2008 Kimko, HC, Reele, SS, Holford, NH & Peck, CC Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by ... Nature.com BOLDER II STUDY CONFIRMS THERAPEUTIC POTENTIAL OF … - Oct 21, 2005 Newly released top-line results from the BOLDER II (BipOLar DEpRession) study have underlined the potential for SEROQUEL (quetiapine fumarate) in the ... Free with registration - Asia Africa Intelligence Wire - AccessMyLibrary.com eLab - Pharmacology Anti-psychotic drug warning - May 27, 2008 ..."Newer anti-psychotic drugs (olanzapine, quetiapine fumarate and risperidone) have been on the market for more than a decade and are commonly used to treat ... Scientist Live Using Disease Progression Models as a Tool to Detect Drug Effect - May 16, 2007 Kimko, HC, Reele, SS, Holford, NH & Peck, CC Prediction of the outcome of a phase 3 clinical trial of an antischizophrenic agent (quetiapine fumarate) by ... Nature.com AstraZeneca Submits Seroquel XR™ in Europe for the Treatment of Major... - Jun 11, 2008 AstraZeneca today announced that the company has submitted applications in the European Union (EU) for once-daily SEROQUEL XR™ (quetiapine fumarate) ... webwire.com Federal Register 2007 - 72 FR 30386 Draft Guidances for Industry … - May 31, 2007 Sodium Perindopril Erbumine Pilocarpine HCl Pravastatin Sodium Q Quetiapine Fumarate Quinapril HCl R Raloxifene HCl Ramipril Ribavirin (multiple dosage ... Pay-Per-View - Federal Register 2007 - Loislaw AstraZeneca bids $15.6B for MedImmune; posts 13% 1st-qtr 2007 EPS … - Apr 30, 2007 Seroquel (quetiapine fumarate), Crestor (rosuvastatin), Arimidex (anastrozole) and Symbicort (budesonide and formoterol) - combined sales of which ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Atypical Antipsychotics Have Very Different Adverse Effect Profiles... - Mar 13, 2006 3 As reflected in our sample, there is less experience with quetiapine fumarate: this drug accounted for only 2% of atypical antipsychotic use in our study. ... Archives of Internal Medicine NEW HOPE FOR PATIENTS WITH BIPOLAR DISORDER AND … - Sep 19, 2006 Quetiapine (quetiapine fumarate) has a well-established safety and efficacy profile and to date over 16 million people have been treated with quetiapine ... Free with registration - AsiaPulse News - AccessMyLibrary.com BOLDER II (BipOLar DEpRession) study - Quetiapine effective in... - Oct 24, 2005 Newly released top-line results from the BOLDER II (BipOLar DEpRession) study have underlined the potential for SEROQUEL (quetiapine fumarate) in the ... RxPG NEWS AstraZeneca's Once-Daily SEROQUEL XR Extended-Release Tablets … - Aug 31, 2007 AstraZeneca announced the Netherlands regulatory authority MEB (Medicines Evaluation Board) has approved SEROQUEL XR™ (quetiapine fumarate) Extended-Release ... Medical News Today - Medical News Today (press release) AstraZeneca Submits sNDA for Seroquel XR for the Treatment of … - May 8, 2008 ...(FDA) for SEROQUEL XR (quetiapine fumarate) Extended-Release Tablets to seek approval for the treatment of generalised anxiety disorder (GAD), ... Lifescience-online Biovail Announces Filing of ANDA for Quetiapine XR Tablets - Dec 1, 2008 300mg and 400mg strengths of quetiapine fumarate extended-release tablets (sold under the brand name Seroquel XR by AstraZeneca Pharmaceuticals LP). ... International Business Times Jail eyes change in drug policy. - Jun 18, 2007 ...risperidone, paroxetine and quetiapine fumarate. There were also medications such as propoxyphene for pain, as well as heart medication. ... Free with registration - Bangor Daily News - AccessMyLibrary.com One-Drug Therapy Works for Bipolar Disorder - Jul 1, 2005 The trial tested two dose levels of Seroquel (quetiapine fumarate), 300 or 600 mg/d, versus placebo. Of the 539 patients enrolled, 358 had bipolar I and 181 ... emaxhealth.com AstraZeneca's Seroquel shows safety in geriatric dementia - Mar 7, 2005 The results of a safety analysis, which was performed as a secondary endpoint, suggest that Seroquel (quetiapine fumarate) did not increase the risk of ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones FDA Approves Astrazeneca's Once-Daily Seroquel XR(TM) Extended- … - May 18, 2007 ...has approved SEROQUEL XR(TM) (quetiapine fumarate) Extended-Release Tablets, a once-daily medicine for the treatment of schizophrenia in adult patients. ... Free with registration - PR Newswire - AccessMyLibrary.com Are mentally ill inmates getting the right meds? - Jul 8, 2007 ...about 9 percent come into the jail taking antipsychotic drugs such as clozapine, prolixin, haloperdol and quetiapine fumarate, better known as Seroquel. ... Herald-Times - The Herald-Times (subscription) Short-term use of antipsychotics in older adults with dementia linked... - May 26, 2008 Newer antipsychotic drugs (olanzapine, quetiapine fumarate and risperidone) have been on the market for more than a decade and are commonly used to treat ... Genetic Engineering News - Genetic Engineering News (press release) First study to test antipsychotic on depressive phase - Jul 4, 2005 The trial tested two dose levels of Seroquel (quetiapine fumarate), 300 or 600mg/d, versus placebo. Of the 539 patients enrolled, 358 had bipolar I and 181 ... RxPG NEWS AstraZeneca Announces New Program That Offers Significant and … - Nov 9, 2006 CRESTOR(R) (rosuvastatin), SEROQUEL(R) (quetiapine fumarate), TOPROL XL(R) (metoprolol succinate) and ARIMIDEX(R) (anastrozole). ... RedOrbit NIMH-Funded Study Examines the Use of Antipsychotic Medications for … - Sep 19, 2005 ...including SEROQUEL(R) (quetiapine fumarate), and a first generation antipsychotic medication for the treatment of schizophrenia. ... RedOrbit Brand Names/Synonyms: quetiapine fumarate is also known by the following brand names and/or synonymsCHEMBANK1802; Quetiapin Hemifumarate; Quetiapine; Quetiapine Fumarate; Quetiapine Hemifumarate; Seroquel; ZD5077 Drug Category: quetiapine fumarate is categorized under the following by the FDA: Antipsychotics; ATC:N05AH04 Dosage Forms: TABLET Absorption: Rapidly and well absorbed. Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: Not Available |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |